Page last updated: 2024-09-05

lapatinib and thienopyrimidine

lapatinib has been researched along with thienopyrimidine in 1 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (thienopyrimidine)	Trials (thienopyrimidine)	Recent Studies (post-2010) (thienopyrimidine)
1,919	305	1,442	129	0	87

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caferro, TR; Dickerson, SH; Donaldson, KH; Gaul, MD; Goetz, AS; McDonald, OB; Mullin, RJ; Petrov, KG; Rheault, TR; Rusnak, DW; Shewchuk, LM; Spehar, GM; Truesdale, AT; Uehling, DE; Vanderwall, DE; Wood, ER	1

Other Studies

1 other study(ies) available for lapatinib and thienopyrimidine

Article	Year
Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors. Bioorganic & medicinal chemistry letters, 2009, Feb-01, Volume: 19, Issue:3 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Humans; Inhibitory Concentration 50; Lapatinib; Models, Chemical; Molecular Conformation; Pyrimidines; Quinazolines; Receptor, ErbB-2	2009

Article

Year

Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors.

Bioorganic & medicinal chemistry letters, 2009, Feb-01, Volume: 19, Issue:3

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Humans; Inhibitory Concentration 50; Lapatinib; Models, Chemical; Molecular Conformation; Pyrimidines; Quinazolines; Receptor, ErbB-2

2009